title: [Treatment of non small cell lung cancer].
abstract: According to the recent data lung cancer in Czech republic is the most common malignancy in men (incidence 93/100 000) and is the leading cause of cancer death in men (mortality 90/100 000). In women is the incidence of lung cancer 30/100 000. Non-small-cell lung cancer (NSCLC) accounts for 70% to 75% of all lung cancers, while small-cell lung cancer (SCLC) accounts for 25% to 30% of cases. These two types of lung cance have a different biological characteristics which leads to a different approach in the treatment of NSCLC and SCLC. The treatment of NSCLC is based on clinical stage of disease and different treatment modalities alone or in combination are used: surgery, radiotherapy, chemotherapy and recently a novel treatment strategy--targeted therapy with biologic agents.
authors.affiliation: Klinika nemocí plicních a tuberkulózy LF MU a FN Brno. jskric@fnbrno.cz
authors.forename: J
authors.initials: J
authors.lastname: Skricková
authors.forename: P
authors.initials: P
authors.lastname: Coupek
authors.forename: L
authors.initials: L
authors.lastname: Babicková
authors.forename: M
authors.initials: M
authors.lastname: Tomísková
authors.forename: J
authors.initials: J
authors.lastname: Kaplanová
authors.forename: D
authors.initials: D
authors.lastname: Princ
authors.forename: B
authors.initials: B
authors.lastname: Kadlec
authors.forename: S
authors.initials: S
authors.lastname: Spelda
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*